Press Release – December 17, 2018

No Tags | News

 

Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases

 

-Proteograph™ platform yields highly accurate, broad-scale information on health status

and disease not previously possible-

 Advancing pipeline of first-in-class liquid biopsy products with the goal of detecting diseases

at early, pre-symptomatic stages-...read more

Read More